We are live on ! Find out more
GCMG

Gyroscope Capital Management Group Portfolio holdings

AUM $436M
1-Year Est. Return 17.45%
This Fund
S&P 500
This Quarter Est. Return
+8.88%
1 Year Est. Return
+17.45%
3 Year Est. Return
+24.82%
5 Year Est. Return
+39.51%
10 Year Est. Return
AUM
$277M
AUM Growth
+$24.8M
Cap. Flow
+$2.34M
Cap. Flow %
0.85%
Top 10 Hldgs %
38.23%
Holding
134
New
14
Increased
58
Reduced
33
Closed
18

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$10.3M
2
WMT icon
Walmart Inc
WMT
+$7.28M
3
HPQ icon
HP
HPQ
+$6.84M
4
BBY icon
Best Buy
BBY
+$6.83M
5
VIAB
Viacom Inc. Class B
VIAB
+$6.25M

Sector Composition

Rank Sector Weight
1 Healthcare 16.62%
2 Technology 16.26%
3 Financials 11.92%
4 Materials 8.3%
5 Communication Services 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRK.B icon
101
Berkshire Hathaway Class B
BRK.B
$1.11T
$453K 0.16%
2,000
-455
-19% -$98.8K
MMM icon
102
3M
MMM
$91.4B
$413K 0.15%
2,799
-59
-2% -$8.26K
XMLV icon
103
Invesco S&P MidCap Low Volatility ETF
XMLV
$751M
$404K 0.15%
+7,507
New +$398K
XLB icon
104
State Street Materials Select Sector SPDR ETF
XLB
$8.36B
$379K 0.14%
12,348
+270
+2% +$7.98K
AMGN icon
105
Amgen
AMGN
$204B
$342K 0.12%
1,417
-7
-0.5% -$1.54K
CSCO icon
106
Cisco
CSCO
$457B
$314K 0.11%
6,555
IJT icon
107
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.37B
$299K 0.11%
3,090
-4
-0.1% -$369
USB icon
108
US Bancorp
USB
$99.6B
$288K 0.1%
4,861
-100
-2% -$5.78K
BMY.RT
109
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$268K 0.1%
+89,052
New +$232K
TFC icon
110
Truist Financial
TFC
$63.4B
$239K 0.09%
+4,235
New +$229K
LLY icon
111
Eli Lilly
LLY
$1,000B
$237K 0.09%
+1,803
New +$209K
CVX icon
112
Chevron
CVX
$385B
$223K 0.08%
1,848
-36
-2% -$4.24K
BMY icon
113
PUT
Bristol-Myers Squibb
BMY
$134B
$85K 0.03%
+701
New +$40.1K
ED icon
114
PUT
Consolidated Edison
ED
$39.8B
$21K 0.01%
15,500
SPY icon
115
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$806B
$5K ﹤0.01%
+11,300
New +$3.48M
IBM icon
116
PUT
IBM
IBM
$213B
$1K ﹤0.01%
+1,569
New +$204K
ANGL icon
117
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.04B
-7,517
Closed -$218K
BBY icon
118
Best Buy
BBY
$18B
-104,074
Closed -$6.83M
FLOT icon
119
iShares Floating Rate Bond ETF
FLOT
$10.3B
-5,767
Closed -$293K
GOVI icon
120
Invesco Equal Weight 0-30 Year Treasury ETF
GOVI
$1.22B
-7,660
Closed -$397K
HPQ icon
121
HP
HPQ
$24.8B
-371,665
Closed -$6.84M
IBCP icon
122
Independent Bank Corp
IBCP
$793M
-8,233
Closed -$171K
IBCP icon
123
PUT
Independent Bank Corp
IBCP
$793M
-8,200
Closed -$2K
LKQ icon
124
LKQ Corp
LKQ
$5.91B
-28,350
Closed -$860K
MMM icon
125
PUT
3M
MMM
$91.4B
-2,631
Closed -$4K

Similar funds

Gyroscope Capital Management Group's Q4 2019 Portfolio in Review

As of Q4 2019, Gyroscope Capital Management Group held 134 positions worth $277M, up 9.8% from $252M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Gyroscope Capital Management Group's Q4 2019 filing shows 14 new, 58 increased, 33 reduced and 18 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 27,880 shares worth $8.97M. The largest sale was Celgene Corp, an estimated $10.3M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

  • Gyroscope Capital Management Group's largest Q4 2019 buy was State Street SPDR S&P 500 ETF Trust: 27,880 shares worth $8.97M.
  • Gyroscope Capital Management Group added most to Bristol-Myers Squibb in Q4 2019, an estimated $7.73M increase.
  • Gyroscope Capital Management Group's biggest Q4 2019 reduction was Marathon Petroleum, cutting an estimated $2.33M.
  • Gyroscope Capital Management Group fully exited Celgene Corp in Q4 2019, selling an estimated $10.3M.
  • Gyroscope Capital Management Group's ten largest holdings make up 38% of its $277M portfolio in Q4 2019.
  • Gyroscope Capital Management Group opened 14 new positions and closed 18 in Q4 2019.
  • Gyroscope Capital Management Group's portfolio value rose 9.8% quarter-over-quarter to $277M.

Based on Gyroscope Capital Management Group's 13F filing for Q4 2019, filed 29 Jan 2020.